Telemetry Investments, L.L.C. - Q3 2019 holdings

$34.7 Million is the total value of Telemetry Investments, L.L.C.'s 53 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 73.3% .

 Value Shares↓ Weighting
CELG BuyCELGENE CORP$2,383,000
+315.9%
24,000
+287.1%
6.87%
+1451.5%
WCG BuyWELLCARE HEALTH PLANS INC$2,099,000
-1.8%
8,100
+8.0%
6.05%
+266.5%
AGN NewALLERGAN PLC$1,969,00011,700
+100.0%
5.68%
ZSAN BuyZOSANO PHARMA CORP$1,133,000
-45.3%
726,358
+14.6%
3.27%
+104.1%
MDSO BuyMEDIDATA SOLUTIONS INC$897,000
+219.2%
9,800
+216.1%
2.59%
+1092.2%
DERM BuyDERMIRA INC$882,000
+16.1%
138,000
+73.6%
2.54%
+333.4%
MLNX BuyMELLANOX TECHNOLOGIES LTD$689,000
+10.2%
6,289
+11.4%
1.99%
+311.4%
GSAT BuyGLOBALSTAR INC$657,000
-10.7%
1,589,041
+3.7%
1.90%
+233.0%
VRAY BuyVIEWRAY INC$440,000
-35.6%
151,557
+95.6%
1.27%
+140.3%
STML BuySTEMLINE THERAPEUTICS INC$416,000
-20.2%
40,000
+17.6%
1.20%
+198.5%
ACIA NewACACIA COMMUNICATIONS INC$392,0006,000
+100.0%
1.13%
CI BuyCIGNA CORP NEW$350,000
+3.2%
2,305
+7.2%
1.01%
+285.1%
CBLK NewCARBON BLACK INC$338,00013,000
+100.0%
0.98%
ELGXQ BuyENDOLOGIX INC$323,000
+14.1%
81,460
+108.4%
0.93%
+325.6%
TCON BuyTRACON PHARMACEUTICALS INC$321,000
-31.4%
717,800
+4.4%
0.93%
+155.8%
WFC BuyWELLS FARGO CO NEW$312,000
+9.9%
6,180
+3.0%
0.90%
+311.0%
SRRA BuySIERRA ONCOLOGY INC$307,000
-27.3%
786,773
+4.3%
0.88%
+171.5%
ACRS BuyACLARIS THERAPEUTICS INC$232,000
-44.1%
214,593
+13.2%
0.67%
+108.4%
BID NewSOTHEBYS$224,0003,925
+100.0%
0.65%
BAM NewBROOKFIELD ASSET MGMT INCcl a ltd vt sh$221,0004,166
+100.0%
0.64%
GWR NewGENESEE & WYO INCcl a$221,0002,000
+100.0%
0.64%
GCI NewGANNETT CO INC$189,00017,600
+100.0%
0.54%
CDOR NewCONDOR HOSPITALITY TR INC$172,00015,583
+100.0%
0.50%
SNDX NewSYNDAX PHARMACEUTICALS INC$97,00013,000
+100.0%
0.28%
ORMP NewORAMED PHARM INC$32,00010,000
+100.0%
0.09%
ARTX NewAROTECH CORP$29,00010,000
+100.0%
0.08%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
RIGEL PHARMACEUTICALS INC33Q4 20221.7%
AFFIMED N V31Q4 20223.9%
GLOBALSTAR INC30Q4 20222.5%
VIEWRAY INC23Q4 20222.1%
SPDR GOLD TRUST22Q4 20222.3%
ADMA BIOLOGICS INC21Q4 20222.9%
STEMLINE THERAPEUTICS INC21Q1 20201.2%
SPDR S&P 500 ETF TR20Q4 202253.9%
KADMON HLDGS INC19Q2 20217.0%
EIGER BIOPHARMACEUTICALS INC19Q4 20226.7%

View Telemetry Investments, L.L.C.'s complete holdings history.

Latest significant ownerships (13-D/G)
Telemetry Investments, L.L.C. Q3 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Xtant Medical Holdings, Inc.February 13, 2020752,9155.7%
Orexigen Therapeutics, Inc.February 14, 20191,295,8446.4%
Xtant Medical Holdings, Inc.February 14, 20181,416,3397.2%

View Telemetry Investments, L.L.C.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2023-02-14
13F-HR2022-11-17
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15
13F-HR2021-08-16
13F-HR2021-05-17
13F-HR2021-02-16
13F-HR2020-11-16

View Telemetry Investments, L.L.C.'s complete filings history.

Compare quarters

Export Telemetry Investments, L.L.C.'s holdings